During the past decade, Shizuoka Children's Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shizuoka Children's Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Takeda" with 2 trials sponsored, "Children's Healthcare of Atlanta" with 1 trials sponsored and "Genzyme, a Sanofi Company" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shizuoka Children's Hospital" #1 collaborator was "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator, "Children's of Alabama" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Maruishi Pharmaceutical" with 1 trials as a collaborator and "The Hospital for Sick Children" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Shizuoka Children's Hospital" are "Acute Kidney Injury" (1 trials), "Acute Lymphoblastic Leukemia" (1 trials), "COVID" (1 trials), "Growth Hormone Deficiency" (1 trials) and "Hemophilia A" (1 trials). Many other conditions were trialed in "Shizuoka Children's Hospital" in a lesser frequency.

Most popular intervention types in "Shizuoka Children's Hospital" are "Drug" (10 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Autologous cardiac stem cells (JRM-001)" (1 trials), "Clofarabine" (1 trials), "Dexmedetomidine hydrochloride" (1 trials), "Emicizumab" (1 trials) and "Fesoterodine BIC 2 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shizuoka Children's Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Shizuoka Children's Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Shizuoka Children's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shizuoka Children's Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".